Arcutis Biotherapeutics Inc (ARQT)
9.365
+0.24
(+2.69%)
USD |
NASDAQ |
May 20, 16:00
9.26
-0.10
(-1.12%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Assets (Quarterly): 478.54M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 478.54M |
December 31, 2023 | 341.36M |
September 30, 2023 | 292.96M |
June 30, 2023 | 320.69M |
March 31, 2023 | 379.46M |
December 31, 2022 | 449.27M |
September 30, 2022 | 508.91M |
June 30, 2022 | 300.46M |
March 31, 2022 | 364.11M |
December 31, 2021 | 408.15M |
Date | Value |
---|---|
September 30, 2021 | 387.01M |
June 30, 2021 | 432.89M |
March 31, 2021 | 471.42M |
December 31, 2020 | 298.27M |
September 30, 2020 | 198.01M |
June 30, 2020 | 231.97M |
March 31, 2020 | 254.39M |
December 31, 2019 | 107.01M |
September 30, 2019 | 28.30M |
December 31, 2018 | 51.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.30M
Minimum
Sep 2019
508.91M
Maximum
Sep 2022
329.12M
Average
341.36M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
AdaptHealth Corp | 4.504B |
Prestige Consumer Healthcare Inc | 3.318B |
Pfizer Inc | 221.10B |
Adverum Biotechnologies Inc | 267.83M |
Karuna Therapeutics Inc (DELISTED) | 1.336B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 253.60M |
Shareholders Equity (Quarterly) | 224.94M |
Debt to Equity Ratio | 0.9016 |
Current Ratio | 9.894 |
Net Debt Paydown Yield | -0.09% |